CA2140427A1 - A two component fibrin-glue composition for improving in vitro fertilization - Google Patents

A two component fibrin-glue composition for improving in vitro fertilization

Info

Publication number
CA2140427A1
CA2140427A1 CA002140427A CA2140427A CA2140427A1 CA 2140427 A1 CA2140427 A1 CA 2140427A1 CA 002140427 A CA002140427 A CA 002140427A CA 2140427 A CA2140427 A CA 2140427A CA 2140427 A1 CA2140427 A1 CA 2140427A1
Authority
CA
Canada
Prior art keywords
component
composition
fibrin
glue
fibrinogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002140427A
Other languages
English (en)
French (fr)
Inventor
Efrach Barnea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opperbas Holding BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2140427A1 publication Critical patent/CA2140427A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002140427A 1992-07-18 1993-07-09 A two component fibrin-glue composition for improving in vitro fertilization Abandoned CA2140427A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92112295 1992-07-18
EP92112295.8 1992-07-18
EP93105298.9 1993-03-30
EP93105298 1993-03-30

Publications (1)

Publication Number Publication Date
CA2140427A1 true CA2140427A1 (en) 1994-02-03

Family

ID=26131003

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002140427A Abandoned CA2140427A1 (en) 1992-07-18 1993-07-09 A two component fibrin-glue composition for improving in vitro fertilization

Country Status (12)

Country Link
JP (1) JPH08502035A (cs)
KR (1) KR950702434A (cs)
AT (1) ATE151295T1 (cs)
AU (1) AU4566893A (cs)
CA (1) CA2140427A1 (cs)
CZ (1) CZ5495A3 (cs)
DE (1) DE69309685T2 (cs)
FI (1) FI950194A0 (cs)
HU (1) HUT71873A (cs)
IL (1) IL106293A0 (cs)
SK (1) SK5095A3 (cs)
WO (1) WO1994002182A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691858B1 (en) * 1993-03-30 1999-12-15 Omrix Biopharmaceuticals S.A. Two component fibrin glue
US5411885A (en) * 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
AU3145795A (en) * 1994-07-26 1996-02-22 Children's Medical Center Corporation Fibrin-cell suspension for construction of new tissue
DE69629010T2 (de) * 1995-01-16 2004-04-15 Baxter International Inc., Deerfield Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
WO1999025782A2 (en) * 1997-11-17 1999-05-27 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
US4904259A (en) * 1988-04-29 1990-02-27 Samuel Itay Compositions and methods for repair of cartilage and bone
CH681693A5 (cs) * 1991-02-28 1993-05-14 Pentapharm Ag
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive

Also Published As

Publication number Publication date
ATE151295T1 (de) 1997-04-15
HU9500141D0 (en) 1995-03-28
AU4566893A (en) 1994-02-14
DE69309685T2 (de) 1997-10-16
DE69309685D1 (de) 1997-05-15
IL106293A0 (en) 1993-11-15
JPH08502035A (ja) 1996-03-05
HUT71873A (en) 1996-02-28
FI950194A (fi) 1995-01-17
FI950194A0 (fi) 1995-01-17
KR950702434A (ko) 1995-07-29
CZ5495A3 (en) 1995-06-14
WO1994002182A1 (en) 1994-02-03
SK5095A3 (en) 1995-07-11

Similar Documents

Publication Publication Date Title
EP0155387B1 (en) Fibronolytically active hybrid protein, process for its preparation and pharmaceutical composition
AU735463B2 (en) Expression of active human factor IX in mammary tissue of transgenic animals
Robinson Improved localization of intracellular sites of phosphatases using cerium and cell permeabilization.
EP0123304B1 (en) A method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same
PL184114B1 (pl) Środek farmaceutyczny do inhibicji aktywności czynnika tkankowego
EP0856317A1 (en) A stabilized mixture comprising fibrinogen
Kornalik Toxins affecting blood coagulation and fibrinolysis
JPH04505326A (ja) プラスミノーゲン活性化剤とフィブリン断片との血栓ターゲットの錯体
WO1984001786A1 (en) Enzyme derivatives and their use in the treatment of thrombosis
US4190708A (en) Production of urokinase
JP2000508918A (ja) 精製されたマルチメラーゼ
CA2140427A1 (en) A two component fibrin-glue composition for improving in vitro fertilization
EP0151593A1 (en) ENZYMATIC DERIVATIVES.
EP0125269A1 (en) Pharmaceutically active compounds
Hatton et al. On the interaction of rabbit antithrombin III with the luminal surface of the normal and deendothelialized rabbit thoracic aorta in vitro
CA1283047C (en) Stabilized plasminogen activator precursor and method of producing the same
Bakos et al. Enzymatic and envelope-converting activities of pars recta oviductal fluid from Xenopus laevis
US5811279A (en) Method for activating prothrombin with polyethylene glycol
US4999194A (en) Two-chain urokinase plasminogen activators for treatment of thrombotic disease
EP0251806B1 (en) Plasminogen activator production
Ghorbanpur et al. Purification and partial characterization of a coagulant serine protease from the venom of the Iranian snake Agkistrodon halys
EP0651659B1 (en) A two component fibrin-glue composition for improving in vitro fertilization
KR20010005626A (ko) 혈관 질환의 치료 방법
Chatterjee et al. Purification of human seminal acrosin inhibitor and its kinetics
Endege et al. Purification and characterization of two fibrinolysins from the midgut of adult female Glossina morsitans centralis

Legal Events

Date Code Title Description
FZDE Discontinued